Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04445506 · ClinicalTrials.gov registry record
Short Term Corticosteroids in SARS-CoV2 Patients
A clinical trial, sponsored by The Miriam Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT04445506 is a clinical trial that has completed, run by The Miriam Hospital. The registered enrollment target is 50 participants.
The verdict
NCT04445506 has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The investigators reviewed the charts of SARS-CoV-2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2020-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04445506
The ClinicalTrials.gov registry entry for NCT04445506 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT04445506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04445506 about?
NCT04445506 is a clinical study titled "Short Term Corticosteroids in SARS-CoV2 Patients". The investigators reviewed the charts of SARS-CoV-2 patients with pneumonia and moderate to severely elevated CRP and worsening hypoxemia who were treated with early, short-term dexamethasone.
What is the current status of trial NCT04445506?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-04-01. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT04445506?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04445506?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.